Managing Risks of Stimulant Treatment

Clinical Perspectives 15 (open)
Managing Risks of Stimulant Treatment

Wednesday, October 23, 2013: 1:00 PM-4:00 PM

Chairs:

Jodi Gold, MD and John T. Walkup, MD

Discussant:

John T. Walkup, MD

15.1

Stimulant Medication and Cardiac Risk in Pediatric ADHD
Paul Hammerness, MD Harvard Medical School and Massachusetts General Hospital, Newton, MA

15.2

ADHD Medication and Decreased Growth
James J. McGough, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA

15.3

Psychostimulant Medication and Tics
Michael H. Bloch, MD, MS Yale University, Hamden, CT

15.4

Managing Sleep and Psychiatric Side Effects of Stimulants in Pediatric ADHD
Jodi Gold, MD Weill Cornell Medical College, New York, NY